Skip to nav Skip to content
Leaders celebrate the grand opening of the Moffitt Speros Outpatient Center on Jan. 9.
Leaders celebrate the grand opening of the Moffitt Speros Outpatient Center on Jan. 9.

Moffitt Opens Outpatient Center at Speros

The clinic anchors the first phase of the 775-acre campus

2677 article(s) found

Pope Leo Diagnosed With Lung Cancer After Surgery

Although the stage of the pope’s cancer has not been disclosed, experts say early detection can improve outcomes

A Closer Look into the Future

Moffitt’s digital and translational pathology programs are transforming how patients are diagnosed and treated — all without the traditional microscope

Food for Thought

How Moffitt’s PEARL Kitchen Is Transforming Cancer Nutrition Research

image of a charcuterie board with different meats

When It Comes to Colorectal Cancer Risk, Not All Ultra-Processed Foods Are Equal

New research finds processed meats linked to higher risk, while some grain and dairy products may be associated with lower risk

Program Provides Spanish-Language Resources for Families Affected by Cancer

New educational and therapeutic materials in Spanish help children navigate a parent or loved ones’ cancer diagnosis and support them through the process

When Jenny De Furio was diagnosed with stage 3C breast cancer in 2024, she decided to go on a clinical trial rather than start with the standard of care treatment. She embraced the chance to be part of a more personalized experimental approach.

Thinking Outside the Box With Adaptive Breast Cancer Clinical Trial

Adaptive clinical trial gives earlier stage breast cancer patient chance to pioneer next generation of treatments 

Photo of Dr. Fred Locke on stage at the podium at Cell Coast 2026

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

Surgery has long been the standard of care for women with ductal carcinoma in situ, or noninvasive stage 0 breast cancer.

Is Surgery the Only Option for Women With Stage 0 Breast Cancer?

RECAST clinical trial explores estrogen blockers as a nonsurgical approach

Four women wearing pink shirts with pink breast cancer awareness ribbons

5 Questions About Metastatic Breast Cancer

Moffitt Cancer Center expert explains what you need to know